These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3201387)

  • 1. Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin.
    Abrányi I
    Ther Hung; 1988; 36(2):56-61. PubMed ID: 3201387
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations with high Mydocalm doses in the treatment of internal diseases.
    Udvardi G
    Ther Hung; 1987; 35(1):23-7. PubMed ID: 3438860
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations with higher Mydocalm doses in outpatients of the surgical department.
    Huber L
    Ther Hung; 1986; 34(4):243-7. PubMed ID: 3449980
    [No Abstract]   [Full Text] [Related]  

  • 4. Experiences with the combined use of Mydocalm + Donalgin in the treatment of patients suffering from lumboischialgia.
    Kumin M; Saál M; Ambrózy G
    Ther Hung; 1984; 32(1):26-8. PubMed ID: 6242725
    [No Abstract]   [Full Text] [Related]  

  • 5. Mydocalm treatment of muscular and vascular complaints accompanying climacterics.
    Sásdi A
    Ther Hung; 1992; 40(2):83-5. PubMed ID: 1462282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant effect of oral Mydocalm treatment with massive doses in locomotor disease patients.
    Konrád K
    Ther Hung; 1987; 35(3):152-5. PubMed ID: 3438877
    [No Abstract]   [Full Text] [Related]  

  • 7. Mydocalm (Tolperison) in the treatment of myogenic dorsal pain.
    Ammer K
    Ther Hung; 1980; 28(2):67-9. PubMed ID: 6451044
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose Mydocalm therapy in certain myogenous headaches.
    Csányi L
    Ther Hung; 1989; 37(2):115-8. PubMed ID: 2686081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of the myorelaxant action of mydocalm in the clinical practice.
    Perényi G
    Ther Hung; 1978; 26(3):107-10. PubMed ID: 725813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic experiences with the myotonolytic agent, Mydocalm in angio-organopathies, angioneuropathies and angiolopathies].
    Hackel F
    Dtsch Gesundheitsw; 1966 Jan; 21(4):171-6. PubMed ID: 5939327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peripheral vascular diseases and generalized scleroderma treated with mydocalm].
    Lukasiak B; Szczepański A; Rózański J; Wnorowski J
    Przegl Dermatol; 1973; 60(3):383-9. PubMed ID: 4748081
    [No Abstract]   [Full Text] [Related]  

  • 12. Several years observations with Mydocalm muscle relaxant in locomotor disease patients.
    Gálos G
    Ther Hung; 1992; 40(2):69-71. PubMed ID: 1462278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of mydocalm in the treatment of vascular diseases of the extremities].
    Liubishchev SA
    Klin Med (Mosk); 1967 Jan; 45(1):100-2. PubMed ID: 5613382
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive postoperative mydeton therapy of traumatological patients.
    Dömötör E
    Ther Hung; 1989; 37(4):230-3. PubMed ID: 2631291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations with high-dose Mydocalm therapy.
    Kiss AM; Martos J
    Ther Hung; 1993; 41(2):51-4. PubMed ID: 8278938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations with Mydocalm in angiological practice.
    Balogh A
    Ther Hung; 1981; 29(2):96-99. PubMed ID: 7188136
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations with intensive Mydocalm treatment in neurological cases.
    Perényi G
    Ther Hung; 1987; 35(2):66-70. PubMed ID: 3326207
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical examination of the synergistic effect of niflumic acid and tolperisone in genicular arthritis.
    Dömötör E
    Ther Hung; 1979; 27(3):129-33. PubMed ID: 531773
    [No Abstract]   [Full Text] [Related]  

  • 19. Several years of observation with Mydeton in the treatment of lockjaw.
    Inovay J; Katona J
    Ther Hung; 1991; 39(4):185-7. PubMed ID: 1811331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of mydocalm in peripheral arterial disease.
    MOLNAR L
    Ther Hung; 1962; 10():10-2. PubMed ID: 13935926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.